Skip to content

Validation of French Version of LCADL and Dyspnea-12

Validation of the French Version of the London Chest Activity of Daily Living Scale (LCADL) and the Dyspnea-12 Questionnaire

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02555202
Acronym
LCADL
Enrollment
50
Registered
2015-09-21
Start date
2015-10-15
Completion date
2016-09-30
Last updated
2017-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Copd

Keywords

dyspnea

Brief summary

The main objective of this study is to develop and to validate a French version of the London Chest Activity of Daily Living (LCADL) and the Dyspnea 12 and to determine the reliability of this version for the evaluation of the dyspnea in the Activity of Daily Living in COPD patients (stages severe and very severe).

Interventions

None listed

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* COPD with FEV1\< 50% of predictive value

Exclusion criteria

* FEV1\> 50% of predictive value * Patients with an exacerbation of COPD in the previous 30 days the inclusion

Design outcomes

Primary

MeasureTime frameDescription
the Saint-Georges questionnaire, item Activity15 daysby comparison with item activities of the Saint-Georges questionnaire for the LCADL
MMRC Dyspnea scale15 daysby comparison with MMRC dyspnea scale for the dyspnea 12

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026